Product Description
Four-Pathway Metabolic & Satiety Research Blend
RETA-3 / Cagrilintide is a dual-compound research blend containing RETA-3 5mg and Cagrilintide 5mg. The formulation provides a framework for studying four complementary metabolic and appetite-related receptor pathways: GLP-1, GIP, glucagon, and amylin signaling.
RETA-3 is studied as a triple-receptor agonist acting across GLP-1, GIP, and glucagon pathways. Research examines these pathways in relation to insulin secretion, appetite signaling, glucose regulation, nutrient metabolism, and energy-expenditure mechanisms.
Cagrilintide is a long-acting amylin analog investigated for its activity at amylin receptors and associated central nervous system pathways. Research focuses on satiety signaling within regions such as the hypothalamus and area postrema, along with meal-size regulation, prolonged fullness, and gastric-emptying pathways.
Because the two compounds act through distinct but complementary signaling networks, the blend provides a multi-pathway experimental framework for examining systemic metabolic regulation alongside central satiety and meal-control signaling. This enables investigation of how overlapping incretin, glucagon, and amylin pathways may interact within energy-balance models.
Combination research is particularly relevant to models examining body-weight regulation, fat-mass changes, appetite suppression, portion control, postprandial glucose dynamics, insulin responsiveness, and energy expenditure through multiple receptor systems rather than a single signaling pathway.
Key Research Areas
🧬
GLP-1 receptor signaling in research models examining appetite regulation, glucose-dependent insulin response, gastric function, and nutrient-associated metabolic signaling
🔗
GIP receptor signaling in models investigating insulin secretion, nutrient sensing, glucose metabolism, and complementary incretin-pathway activity
⚡
Glucagon receptor activity in research examining energy expenditure, substrate utilization, metabolic rate, and energy-balance signaling
🍽️
Amylin receptor signaling in Cagrilintide research involving satiety, meal termination, portion-size regulation, and prolonged fullness
🧠
Central appetite and satiety pathways involving hypothalamic and area-postrema signaling associated with hunger perception and meal-size control
⏳
Gastric-emptying regulation in experimental models examining meal transit, prolonged gastric fullness, and post-meal satiety signaling
📊
Glycemic regulation in models examining insulin responsiveness, postprandial glucose dynamics, and coordinated metabolic signaling
🔥
Energy expenditure and substrate metabolism through investigation of glucagon-associated pathways and broader energy-balance mechanisms
📉
Body-weight and fat-mass research evaluating changes in appetite, food intake, satiety, energy expenditure, and body-composition markers
🔬
Multi-receptor pathway interaction in experimental models combining incretin, glucagon, and amylin signaling within a single metabolic research framework
This 10 mg presentation supports controlled multi-receptor metabolic research designs, making it suitable for investigations across GLP-1, GIP, glucagon, and amylin signaling; appetite and satiety regulation; gastric emptying; insulin response; glucose regulation; energy expenditure; meal-size control; body-weight dynamics; and fat-mass research.
Intended Use
📦 Format: Lyophilized blend (10mg total)
🧬 Composition: RETA-3 5mg + Cagrilintide 5mg
⚠️ Use: For laboratory research use only. Not for human or veterinary use.
Why Researchers Choose This Blend
🧬
Four-receptor pathway coverage provides an integrated framework spanning GLP-1, GIP, glucagon, and amylin signaling rather than examining a single metabolic pathway in isolation.
🍽️
Complementary appetite-control mechanisms allow investigation of broad metabolic hunger signaling alongside amylin-associated satiety, portion-control, and gastric-fullness pathways.
⚡
Integrated energy-balance research combines appetite-related signaling with glucagon-associated energy expenditure and substrate-utilization pathways.
📊
Broad glycemic research relevance supports models involving insulin response, incretin activity, postprandial glucose regulation, and metabolic homeostasis.
📉
Comprehensive body-composition research utility provides a controlled framework for studying food intake, meal size, satiety duration, energy expenditure, body weight, and fat-mass dynamics.
Product Notes
✅ Research category: Multi-receptor metabolic, appetite, satiety, and body-composition signaling
✅ Study context: Laboratory and preclinical research models
✅ Blend composition: RETA-3 5mg and Cagrilintide 5mg
✅ RETA-3 focus: GLP-1, GIP, and glucagon receptor signaling; insulin response; appetite pathways; glucose metabolism; and energy expenditure
✅ Cagrilintide focus: Amylin receptor signaling, central satiety pathways, meal-size regulation, gastric emptying, and prolonged fullness
✅ Metabolic focus: Glycemic regulation, energy balance, substrate metabolism, appetite signaling, and postprandial response
✅ Body-composition focus: Food intake, portion control, body-weight dynamics, fat-mass research, and multi-pathway energy-balance models
